Skip to main content

Intellicheck Inc

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

IDN$2.11+3.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

NOTES TO FINANCIAL STATEMENTS

  1. NATURE OF BUSINESS

Business

Intellicheck, Inc. (the “Company” or “Intellicheck”) is a prominent technology company that is engaged in developing, integrating and marketing identity verification solutions to address challenges that include commercial retail and banking fraud prevention. Intellicheck’s products include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices. Intellicheck continues to develop and release innovative products based upon its rich patent portfolio consisting of ten (10) U.S. and one Canadian patents.

Liquidity

For the year ended December 31, 2023, the Company incurred a net loss of $(1,980) and had net cash used in operating activities of $(647). As of December 31, 2023, the Company had cash and cash equivalents of $3,980, short term investments of $5,000, working capital (defined as current assets minus current liabilities) of $7,843 and an accumulated deficit of $133,565. Based on the Company’s business plan and cash resources, Intellicheck expects its existing and future resources and revenues generated from operations to satisfy its working capital requirements for at least the next 12 months from the date of filing.

  1. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The preparation of the Company’s financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes.

Significant estimates and assumptions that affect amounts reported in the financial statements include impairment consideration and valuation of goodwill and intangible assets, deferred tax valuation allowances, allowance for doubtful accounts, revenue recognition (including breakage revenue) and the fair value of stock options granted under the Company’s Equity compensation plan. Due to the inherent uncertainties involved in making estimates, actual results reported in future periods may be different from those estimates. ASC Topic 718, "Compensation - Stock Compensation", establishes fair value as the measurement objective in accounting for equity payment arrangements and requires all companies to apply a fair-value based measurement method in accounting for all equity payment transactions with employees. The Company determined the fair value of these awards utilizing a Black-Scholes option pricing model.

Allowance for Credit Losses

Effective January 1, 2023 Intellicheck applied the new standard ASU 2016-13, codified as ASC 326. This impacts how the allowance for doubtful accounts is calculated. Prior to ASC-326, Intellicheck would not recognize bad debt expense until the loss from customer non-payment was probable of occurring. Under the new model, Intellicheck’s allowance for doubtful accounts reflects the Company’s estimate of all expected future credit losses from its current customer balances. Under the new guidance, the Company has applied a loss rate method which takes historical data as the basis for calculating the allowance amount, along with accounting for other factors like current and forecasted market conditions, and potential future impacts to the industry. In estimating whether accounts receivable will be collected, the Company performs evaluations of customers and continuously monitors collections and payments and estimates an allowance for credit losses based on collections experience to date and any specific collection issues that have been identified. The allowance for credit losses is recorded in the period in which revenue is recorded or when collection risk is identified.

Cash and Cash Equivalents

We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. Our cash and cash equivalents consist primarily of both cash on deposits with banks, which are maintained with major financial institutions in the United States, and money market funds. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000, however amounts may exceed FDIC insured limits. The Company has not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cash bank accounts.

Short-term investments

Short-term investments include investments in U.S. treasury notes. Debt investments with original maturities at the date of purchase greater than approximately three months but less than a year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the Company holds are classified as "held-to-maturity" as the Company has the intent and ability to hold these investments until maturity. See Note 3 for more detail and a breakdown of the Company's short-term investments.

Long-Lived Assets and Impairment of Long-Lived Assets

The Company’s long-lived assets include property and equipment, goodwill, and intangible assets.

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be fully recoverable in accordance with Accounting Standards Codification (“ASC”) 350 (“Intangibles – Goodwill and Other”) and ASC 360 (“Property, Plant and Equipment”). To determine recoverability of its long-lived assets, the Company evaluates the probability that future undiscounted net cash flows, without interest charges, will be less than the carrying amount of the assets. Impairment is measured at fair value.

Property and Equipment

Property and equipment are recorded at cost and are depreciated over their estimated useful lives ranging from three toseven-years using the straight-line method. Expenditures for maintenance and repairs are charged to operations as incurred. See Note 4.

Goodwill

Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC 350, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assesses qualitative factors to determine whether it is necessary to perform step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

The Company performed its annual impairment test of goodwill in the fourth quarter for the years ended December 31, 2023 and December 31, 2022, more detail about this is referenced in Note 5. For the years ended December 31, 2023 and 2022, the Company determinedno impairment charge was required.

Intangible Assets

Intangible assets include patents, copyrights, developed technology and capitalized software development costs. The Company amortizes these assets on a straight-line basis over their estimated useful lives, as it represents the pattern of economic benefits consumed. There wereno impairment charges recognized for the years ended December 31, 2023 and 2022. See Note 5.

We capitalize internal-use software costs which includes costs incurred in connection with the development of new software solutions and enhancements to existing software solutions that are expected to result in increased functionality. The costs incurred in the preliminary stages of development are expensed as incurred. Once the software has reached the development stage, internal and external costs, if direct and incremental, are capitalized until the software is complete and available for its intended use. We evaluate the useful lives of these assets and test for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. There wereno impairments of capitalized software development costs for the years ended December 31, 2023 and 2022.

Revenue Recognition and Deferred Revenue

General

Most license fees and services revenue are generated from a combination of fixed-price and per-scan contracts. Under the per-scan revenue model, customers are charged a fee each time the customer scans an identity document, such as a driver’s license, with the Company’s software. Under the fixed-price revenue model customers are charged a fixed monthly fee either per device or physical business location to access the Company’s software. Under ASC 606, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration expected to be received in exchange for those goods or services. The Company measures revenue based on the consideration specified in a customer arrangement, and revenue is recognized when the performance obligations in an arrangement are satisfied. A performance obligation is a promise in a contract to transfer a distinct service to the customer. The transaction price of a contract is allocated to each distinct performance obligation and recognized as revenue when, or as, the customer receives the benefit of the performance obligation. Customers typically receive the benefit of the Company’s services as they are performed. The Company's performance obligations are satisfied over time, and as a result, we may follow the right to invoice practical expedient meaning we recognize revenue monthly as invoiced based on our contract terms.

The Company has an additional revenue model where customers purchase a predetermined number of transactions for the term of the contract. Customers are charged a fixed monthly fee for a set number of scans (fixed consideration), with any overages charged on a per scan basis (variable consideration). The Company estimates the amount of unused transactions at the end of each contract period and recognizes a portion of that revenue as breakage revenue each reporting period. If the Company expects the customer to use all transactions in the specified service period, the Company will recognize the transaction price as revenue in the specified service period as the promised units of service are transferred to the customer. Alternatively, if the Company expects that the customer cannot or will not use all transactions in the specified service period (referred to as “breakage”), the Company will recognize the estimated breakage amount as revenue ratably over the service period in proportion to the revenue that the Company will recognize for actual transactions used by the customer in the service period. The company does not estimate the variable consideration at any point; rather we calculate and recognize the variable portion at the end of the contract term since these contracts are considered monthly due to the termination clauses included within them. The fixed and variable performance obligations are recognized monthly based on the contract terms.

Invoicing is based on schedules established in customer contracts. Payment terms are generally established from 30 to 60 days from the invoice date. Accordingly, the Company has determined that its contracts do not include a significant financing component. Product returns are estimated and recorded as a reduction to revenue, however, such amounts have been immaterial.

The Company has not capitalized any costs to obtain a contract as the period of amortization for these associated costs would have been recognized over a period that is one year or less and the Company elected the practical expedient to expense those costs as incurred.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

Software as a Service (SaaS)

Software as a service (SaaS) for hosted subscription services requires the Company to provide a stand-ready obligation and allows customers to access a set of data for a predetermined period of time. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the entity’s performance as the entity performs. Accordingly, the revenue should be recognized over time, under the fixed pricing model, based on the usage of the hosted subscription services, which can vary from month to month. Under the per-scan revenue model, the customer requires access to the Company's hosted subscription service but revenue is recognized over time as the customer scans an identity document.

Equipment Revenue

Revenue from the sale of equipment is recognized at a point in time. The point in time that the revenue is recognized is when the customer has control of the equipment which is when the customer receives the benefit and the Company’s performance obligation has been satisfied. Depending on the contract terms, that could either be at the time the equipment is shipped or at the time the equipment is received.

Other Revenue

Other Revenues, which historically have not been material, consist primarily of revenues from other subscription and support services, and extended warranties. The Company’s revenues from other subscription and support services includes jurisdictional updates to certain commercial customers and support services particularly to its Defense ID® customers. These subscriptions require continuing service or post contractual customer support and performance. As the customer obtains access at a point in time but continues to have access for the remainder of the subscription period, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. Accordingly, the revenue is recognized over time based on usage, which can vary from month to month. The revenue is typically based on a formula such as number of locations in a given month multiplied by a fee per location.

Extended warranty revenues are generated when a warranty is provided to the customer separately of other performance obligations when the equipment is sold. As the customer obtains access at a point in time and continues to have access for the remainder of the warranty term, the customer is considered to simultaneously receive and consume the benefits provided by the Company’s performance as the Company performs. The related revenue is recognized ratably over the specified term of the warranty period. The extended warranty is separate from the Company’s standard warranty that it receives from its vendor, which is typically one year.

Disaggregation of revenue

In the following tables, revenue is disaggregated by product and service and the timing of revenue recognition. The table also includes a reconciliation of the disaggregated revenue.

For the Years Ended December 31,
20232022
Products and services
Software as a Service (SaaS)$18,595$15,728
Other14626
Equipment165212
$18,906$15,966
Timing of revenue recognition
Products transferred at a point in time$311$238
Services transferred over time18,59515,728
$18,906$15,966

Contract balances

The current portion of deferred revenue at December 31, 2023 and December 31, 2022 was $2,209 and $906, respectively, and primarily consists of revenue that is recognized over time for software license contracts and hosted subscription services. The changes in these balances are related to the satisfaction or partial satisfaction of these contracts. The entire December 31, 2022, current deferred revenue balance was recognized as revenue in the year ended December 31, 2023. The noncurrent deferred revenue balances were $0 and $1 as of December 31, 2023, and December 31, 2022, respectively.

Transaction price allocated to the remaining performance obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period:

202420252026Total
Software as a Service (SaaS)$2,201$—$—$2,201
Other8——8
$2,209$—$—$2,209

All consideration from contracts with customers is included in the amounts presented above.

Advertising Costs.

Advertising costs, which are charged to expense as incurred and recorded as selling, general and administrative expenses in our statements of operations, were $536 and $683 for the years ended December 31, 2023 and 2022, respectively.

Shipping Costs

The Company’s shipping and handling costs related to sales are included in cost of revenues for all periods presented. All other shipping and handling costs are included as a component of selling, general and administrative expenses within the Statements of Operations.

Loss Contingencies and Legal Costs

The Company accrues loss contingencies that are believed to be probable and can be reasonably estimated. As events evolve during the administration and litigation process and additional information becomes known, the Company reassesses its estimates related to loss contingencies. Legal costs are expensed in the period in which the costs are incurred.

Sales Taxes

Sales and other taxes collected from customers and remitted to governmental authorities are presented on a net basis and thus excluded from revenues.

Income Taxes

The Company accounts for income taxes in accordance with ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss carryforwards. Deferred tax assets and liabilities are measured using expected tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Deferred tax assets are recognized subject to management’s judgment that realization is more likely than not. The Company has recorded a full valuation allowance for its net deferred tax assets as of December 31, 2023 and 2022, due to the uncertainty of the realizability of those assets. See Note 8.

Fair Value of Financial Instruments

The Company adheres to the provisions of ASC 820, “Fair Value Measurement” which requires the Company to calculate the fair value of financial instruments and include this additional information in the notes to financial statements when the fair value of those financial instruments is different than the book value. The Company’s financial instruments include cash and cash equivalents, short-term investments, accounts receivable, other current assets, accounts payable and accrued expenses. At December 31, 2023 and 2022, the carrying value of the Company’s financial instruments approximated fair value, due to their short-term nature. Financial Accounting Standards Board (“FASB”) guidance specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).

The three levels of the fair value hierarchy are as follows:

Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded instruments and listed equities. The Company's Level 1 assets consisted primarily of cash and cash equivalents as well as short-term investments totaling approximately $8,980 and $10,076 as of December 31, 2023 and 2022, respectively.

Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly (e.g., quoted prices of similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active). Level 2 includes financial instruments that are valued using models or other valuation methodologies. The Company had $4 and $54 of Level 2 liabilities as of December 31, 2023 and December 31, 2022 respectively, for the liability-classified stock options. The fair value of these awards were determined by utilizing a Black-Scholes option pricing model.

Level 3—Unobservable inputs for the asset or liability. Financial instruments are considered Level 3 when the fair values are determined using pricing models, discounted cash flows or similar techniques and at least one significant model assumption or input is unobservable. The Company had no Level 3 assets or liabilities as of December 31, 2023 and December 31, 2022. There were no transfers into or out of Level 3 measurements in 2023 and 2022.

Business Concentration and Credit Risk

Financial instruments, which subject the Company to concentrations of credit risk, consist primarily of cash. The Company maintains cash attwo financial institutions. The Company performs periodic evaluations of the relative credit standing of these institutions.

The Company’s sales are principally made to large retail customers, financial institutions concentrated in the United States and to U.S. government entities. The Company performs ongoing credit evaluations, generally does not require collateral, and establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of customers, historical trends, and other market and economic information.

During the year ended December 31, 2023, the Company made sales to three customers that accounted for approximately 47% of revenue,21%,14% and 12%, respectively. The revenue was associated with commercial identity sales customers. These three customers represented 66% of the Company’s December 31, 2023 accounts receivable balance. These three customers accounted for approximately 37%,6%, and 23% , respectively, of the Company's accounts receivable balance at December 31, 2023. During the year ended December 31, 2022, the Company had three customers that accounted for 52% of revenue;22%,17% and 13%, respectively and those same three customers, including one other customer together accounted for 63%;37%,11%,1% and 14%, respectively, of its December 31, 2022 accounts receivable balance.

As of December 31, 2023, the Company hadfour suppliers to produce its input devices. The Company has modified its software to operate in Windows-based systems and can integrate with different hardware platforms that are readily available in the marketplace. The Company does not maintain a manufacturing facility of its own and is not dependent on maintaining its production relationships due to the flexibility of its software to run on multiple existing platforms.

Net Loss Per Share

Basic net loss per share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted average number of shares of common stock and potentially dilutive common stock equivalents outstanding during the period. The dilutive effect of these common stock equivalents comprising of outstanding options, warrants and restricted stock is reflected in diluted earnings per share by application of the treasury stock method. The calculation of diluted net loss per share excludes all anti-dilutive shares. In a period of net loss, all common stock equivalents are considered anti-dilutive.

Years EndedDecember 31,
20232022
Numerator:
Net Loss$(1,980)$(4,159)
Denominator:
Weighted average common shares –
Basic19,243,17918,838,971
Weighted average common shares -
Diluted19,243,17918,838,971
Net Loss per share –
Basic$(0.10)$(0.22)
Diluted$(0.10)$(0.22)

The following table summarizes the common stock equivalents excluded from the 2023 and 2022 loss per diluted share because their effect would be anti-dilutive:

20232022
Stock options1,152,7141,120,244
Restricted stock60,500214,892
Performance stock units—177,688
Total1,213,2141,512,824

The Company accounts for the issuance of equity awards to employees in accordance ASC 718 (“Compensation - Stock Compensation) and ASC 505 (“Equity”), which requires that the cost resulting from all equity payment transactions be recognized in the financial statements. This pronouncement establishes fair value as the measurement objective in accounting for equity payment arrangements and requires all companies to apply a fair value-based measurement method in accounting for all equity payment transactions with employees and directors. All stock-based compensation expenses are included in operating expenses. The Company recognizes compensation expense related to equity grants on a straight-line basis over the requisite service period. See Note 9.

Segment Information

The Company adheres to the provisions of ASC 280 (“Segment Reporting”), which establishes standards for the way public business enterprises report information about operating segments in annual financial statements and requires that those enterprises report selected information about operating segments in financial statements issued to shareholders. The Company’s Chief Operating Decision Maker, its Chief Executive Officer (“CEO”), reviews the financial information presented for purposes of allocating resources and evaluating its financial performance. Accordingly, the Company has determined that it operates in a single reportable segment. All of the Company’s long-lived assets are located in the United States. Since the Company operates inone operating segment, all required financial segment information can be found in the financial statements.

Research and Development

Research and development expenses are expensed as incurred and consist primarily of employee-related expenses (such as salaries, taxes, benefits and stock-based compensation), allocated overhead costs and outside services costs related to the development and improvement of the Company's SaaS applications.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") to measure credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate can now reflect an entity’s current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company concluded that the adoption of this standard, on January 1, 2023, did not have a material impact on its financial statements because of the short-term nature of its outstanding accounts receivable and there have been no significant forward-looking economic conditions identified by the Company that would impact its short-term investments.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances reporting requirements under Topic 280. The enhanced disclosure requirements include: title and position of the Chief Operating Decision Maker (CODM), significant segment expenses provided to the CODM, extending certain annual disclosures to interim periods, clarifying single reportable segment entities must apply ASC 280 in its entirety, and permitting more than one measure of segment profit or loss to be reported under certain circumstances. This change is effective for fiscal years beginning after December 15, 2023 and interim periods beginning after December 15, 2024. This change will apply retrospectively to all periods presented. The Company is currently evaluating the impact of this ASU on its financial statements.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740), which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. The new guidance requires consistent categorization and greater disaggregation of information in the rate reconciliation, as well as further disaggregation of income taxes paid. This change is effective for annual periods beginning after December 15, 2024. This change will apply on a prospective basis to annual financial statements for periods beginning after the effective date. However, retrospective application in all prior periods presented is permitted. The Company is currently evaluating the impact of this ASU on its financial statements.

Revision of Previously Reported Financial Statements

In connection with the preparation of its financial statements for the year ended December 31, 2023, the Company determined that it had a historical state sales and use tax liability related to prior periods that was not reflected in previously issued financial statements. See Note 12 for further details.

Reclassification of Prior Year Presentation

Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on net earnings. An adjustment has been made to the Condensed Statements of Cash Flows to reclassify the allowance for credit losses. This change in classification does not affect previously reported cash flows from operating activities in the Condensed Statements of Cash Flows.

  1. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Short-term investments include investments in U.S. Treasury notes. Short-term investments with original maturities of approximately three months or less from the date of purchase are classified within cash and cash equivalents. Debt investments with original maturities at the date of purchase greater than approximately three months but less than one year are classified as short-term investments, as they represent the investment of cash available for current operations. All short-term investments that the company holds are classified as "held-to-maturity". The Company has accounted for and disclosed the purchase of its short-term investments in accordance with ASC 320 ("Investments - Debt Securities"). The following table summarizes the fair value of cash and cash equivalents, and short-term investments as well as any gross unrealized holding gains and losses as of December 31, 2023. Due to the nature of these assets and the short-term nature of the U.S. treasury notes being held to maturity, both these cash and cash equivalents and short-term investments fall under the Level 1 fair value hierarchy as referenced in Note 2.

As of December 31, 2023
Amortized cost · Gross unrealized holding gains · Gross unrealized holding losses · Estimated fair value
Cash and cash equivalents$3,980$—$—$3,980
U.S. treasury notes (1)5,000——5,000
Total cash, cash equivalents and short-term investments$8,980$—$—$8,980
As of December 31, 2022
Amortized cost · Gross unrealized holding gains · Gross unrealized holding losses · Estimated fair value
Cash and cash equivalents$5,196$—$—$5,196
U.S. treasury notes (2)4,8803(15)4,868
Total cash, cash equivalents and short-term investments$10,076$3$(15)$10,064

(1)These U.S. treasury notes are classified as "held-to-maturity" as they were purchased in August 2023 and will mature in January 2024. Any coupon payments or accretion of discounts from these short-term investments fall under "Interest and other income (expense)" in the Company's Statement of Operations.

(2) These U.S. treasury notes were classified as "held-to-maturity" as they were purchased in December 2022 and matured in July 2023.

The Company didnot hold any securities that were in an unrealized loss position for more than 12 months as of December 31, 2023 and 2022. The Company recognized $206 andzero in realized gains on short-term investments that matured within the years ended December 31, 2023 and 2022, respectively.

  1. PROPERTY AND EQUIPMENT

Property and equipment are comprised of the following as of December 31, 2023 and 2022:

20232022
Computer equipment and software$1,886$1,796
Furniture and fixtures139139
Office equipment618614
2,6432,549
Less – Accumulated depreciation(1,977)(1,800)
$666$749

Depreciation expense for the years ended December 31, 2023 and 2022 amounted to $177 and $180 respectively. Depreciation expense is included in the Statement of Operations within the selling, general and administrative line item.

  1. GOODWILL AND INTANGIBLE ASSETS

Identifiable intangible assets

The following tables set forth the components of intangible assets as of December 31, 2023 and 2022:

EstimatedUsefulLife · As of December 31, 2023
AdjustedCarryingAmount · AccumulatedAmortization · Net
Patents and copyrights2-17 years$375$(300)$75
Developed technology5 years400(307)93
Software development-407—407
$1,182$(607)$575
EstimatedUsefulLife · As of December 31, 2022
AdjustedCarryingAmount · AccumulatedAmortization · Net
Patents and copyrights2-17 years$375$(275)$100
Developed technology5 years400(227)173
$775$(502)$273

The Company has capitalized $407 in software development costs to date. The projects are still in development and not yet ready for their intended use and therefore no estimated useful life has been determined and these costs are not being amortized as of December 31, 2023.

The following summarizes amortization of acquisition related intangible assets included in the Statement of Operations:

Years Ended December 31,
20232022
Cost of revenues$95$95
Selling, general and administrative1010
$105$105

The Company expects amortization expense for the next five succeeding years will be as follows:

2024$105
202539
202620
20274
2028—
$168

These amounts are subject to change based upon the review of recoverability and useful lives that are performed at least annually.

Goodwill

Goodwill represents the excess of purchase price over the fair value of the assets acquired in businesses combinations. Under ASC 350, purchased goodwill is not amortized, but rather is tested for impairment. The Company’s goodwill balance was $8,102 as of December 31, 2023 and 2022. This goodwill resulted from the acquisitions of Mobilisa, Inc. and Positive Access Corporation.

For the years ended December 31, 2023 and 2022, the Company performed its annual impairment test of goodwill in the fourth quarter. Under authoritative guidance, the Company can use industry and Company specific qualitative factors to determine whether it is more likely than not that impairment exists before performing step one of the quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.

The Company performed the first step of the goodwill impairment test to identify potential impairment by comparing the fair value of the Company to its carrying amount, including goodwill. The fair value was determined using the weighting of certain valuation techniques, including both income and market approaches which include a discounted cash flow analysis, an analysis of similar public company financial information, and an analysis of market transactions. Although the Company believes that the factors considered in the impairment analysis are reasonable, changes in any one of the assumptions used could have produced a different result which may have led to an impairment charge.

For the years ended December 31, 2023 and 2022, the Company determined that the fair value of the Company was greater than its carrying amount and therefore the second step of the goodwill impairment test was not required.

  1. DEBT

Revolving Line of Credit

On February 6, 2019, the Company entered into a revolving credit facility with Citi Personal Wealth Management that allows for borrowings up to the lesser of (i) $2,000 or (ii) the collateralized balance in the Company’s existing fixed income investment account with Citi Personal Wealth Management subject to certain limitations. The facility bears interest at a rate consistent of Citi Personal Wealth Management’s Base Rate (8.50% and 7.50% at December 31, 2023 and December 31, 2022) minus 2%. Interest is payable monthly and as of December 31, 2023 and 2022, there wereno amounts outstanding under this facility and unused availability under this facility was $2,000. The Company is not subject to any financial covenants related to this revolving line of credit. This line will remain open as long as the Company maintains depository relationship with the financial institution.

Insurance Financing Arrangement

In February 2023, the Company entered into a financing arrangement related to insurance premiums totaling $49 with an interest rate of 9.47%. The monthly loan payments of $5 were paid to financing company over a period of 11 months. As of December 31, 2023, the Company hadno remaining commitments related to this financing arrangement.The Company was not subject to any financial covenants related to this insurance financing arrangement.

On June 17, 2022, the Company entered a financing arrangement related to insurance premiums totaling $319 with an interest rate of 4.05%. The monthly loan payments of $32 were paid to a separate financing company for a total of 10 months. As of December 31, 2023, the Company hadno remaining commitments related to this financing arrangement.

  1. ACCRUED EXPENSES

Accrued expenses are comprised of the following as of December 31, 2023 and 2022:

20232022
(As Adjusted)
Professional fees$1$259
Payroll and related1,1591,040
Incentive bonuses824846
Sales tax accrual1,064837
Other197174
$3,245$3,156
  1. INCOME TAXES

The Company’s deferred tax assets and liabilities are measured using the enacted tax rates that the Company believes will apply in the years in which temporary differences are expected to be recovered or paid. The Company is subject to federal and state income taxes as a Subchapter C corporation.

The Company’s deferred tax assets are primarily the result of net operating losses (or NOLs). The Company has recorded a valuation allowance against its net deferred tax assets at December 31, 2023 as it is more likely than not that not all of the deferred tax assets will be realized. The valuation is based on management’s assessment that it is more likely than not the NOL carryforwards may not be realized in the foreseeable future due to objective negative evidence that the Company would not generate sufficient taxable income to realize the deferred tax assets.

The provision for income taxes as of December 31, 2023 and 2022 consists of the following:

20232022
Current:
Federal$(12)$—
State(50)124
Total current tax (benefit) expense(62)124
Deferred:
Federal——
State——
Total deferred tax (benefits) expense——
(Benefit) Provision for income taxes$(62)$124

A reconciliation of the statutory U.S. Federal rate to the Company’s effective tax rate as of December 31, 2023 and 2022 is as follows:

2023 · 2022
(As Adjusted)
Federal income tax benefit at statutory rate21.00%21.00%
State income taxes, net of federal benefit0.25(2.20)
Other permanent items(0.30)(0.04)
Stock-based compensation(9.94)(1.99)
Lobbying expense(1.95)(0.92)
Research and development tax credits(9.66)9.92
Cumulative deferred adjustments(31.39)26.14
Rate change(2.22)(18.06)
Change in valuation allowance36.20(36.30)
Other1.07(0.66)
Effective income tax (benefit) expense rate3.06%(3.11)%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets for federal and state income taxes as of December 31, 2023 and 2022 are as follows:

20232022
(As Adjusted)
Deferred tax assets:
Net operating loss carryforwards$5,625$4,889
Payroll related accruals256333
Stock-based compensation88612
Intangible assets9089
Sec. 174 Capitalized costs4681,237
Sales tax accrual245197
Other175
Depreciation5018
Research and development tax credits708906
Total deferred tax assets7,5478,286
Net deferred tax assets7,5478,286
Less: Valuation allowance(7,547)(8,286)
Deferred tax assets, net of allowance$—$—

The Company’s available NOL at December 31, 2023 was approximately $26.3 million, of which $10.9 million expires between 2035 and 2037. In accordance with the Tax Cuts and Jobs Act of 2017 (the "Tax Act"), U.S. NOLs arising in a tax year ending after 2017 in the amount of $15.4 million will not expire, but are subject to 80% limitation on utilization. In addition to the NOLs, the Company has approximately $708 thousand of research and development credits.

The Company files numerous tax returns in various jurisdictions. The Company is not currently under examination by any taxing authority, nor has the Company signed any waiver of the statute of limitations with any taxing authority. The Company remains open to examination by major taxing jurisdictions from 2015 to date. ASC 740 requires evaluation of uncertain tax positions and as of December 31, 2023, the Company has no material uncertain tax positions. There were no tax interest or penalties recorded in the financial statements for the years ended December 31, 2023 and 2022.

The Company recorded an income tax credit of approximately $(62) for the year ended December 31, 2023 related to state taxes. The effective tax rate for the years ended December 31, 2023 and 2022 is different from the tax benefit that would result from applying the statutory tax rates primarily due to the recognition of valuation allowances. In 2023, the valuation allowance decreased by approximately $(739), primarily related to temporary differences arising from Section 174 capitalized costs and stock based compensation.

  1. STOCKHOLDERS’ EQUITY

Series A Convertible Preferred Stock

In January 1997, the Board of Directors authorized the creation of 30,000 class of Series A Convertible Preferred Stock with a par value of $0.01. The Series A Convertible Preferred Stock is convertible into an equal number of common shares at the holder’s option, subject to adjustment for anti-dilution. The holders of Series A Convertible Preferred Stock are entitled to receive dividends as and if declared by the Board of Directors. In the event of liquidation or dissolution of the Company, the holders of Series A Convertible Preferred Stock are entitled to receive all accrued dividends, if applicable, plus the liquidation price of $1.00 per share. As of December 31, 2023, and 2022, there wereno outstanding shares of Series A Convertible Preferred Stock.

To retain and attract qualified personnel necessary for the success of the Company, the Company adopted the 2015 Omnibus Incentive Plan (the “Plan”) covering up to 5,236,000 of the Company’s common shares, pursuant to which officers, directors, key employees and consultants to the Company are eligible to receive incentive stock options, nonqualified stock options and restricted stock units. All the equity compensation plans prior to Company’s 2015 Omnibus Incentive Plan have been closed. The Compensation Committee of the Board of Directors administers this Plan and determines the terms and conditions of stock options granted, including the exercise price. This Plan generally provides that all stock options will expire withinten years of the date of grant. Incentive stock options granted under this Plan must be granted at an exercise price that is not less than the fair market value per share at the date of the grant and the exercise price must not be less than 110% of the fair market value per share at the date of the grant for grants to persons owning more than 10% of the voting stock of the Company. This Plan also entitles non-employee directors to receive grants of non-qualified stock options as approved by the Board of Directors.

The Company uses the Black-Scholes option pricing model to value the options on the grant date. The table below presents the weighted average expected life of the stock options in years. The Company uses the simplified method for all stock options to estimate the expected life of the option and assumes that stock options will be exercised evenly over the period from vesting until the awards expire. Volatility is determined using changes in historical stock prices. The interest rate for periods within the expected life of the award is based on U.S. Treasury yield curve in effect on the grant date. Options, generally, vest fromone year tofour years. The compensation expense is recognized over the requisite service period on a straight-line basis, reduced by forfeitures as they occur.

Certain option awards are classified as liability awards. The fair values of these awards are determined at each reporting period utilizing a Black Scholes option pricing model, and the associated compensation expense (credit) for the reporting period is recorded. The Company recorded $(50) and $(324) of credits to stock-based compensation expense in the years ended December 31, 2023 and 2022, respectively, as a result of the change in fair value of these awards.

The fair value of the Company’s stock options granted in 2023 that are being classified as equity awards were estimated using the Black-Scholes option pricing model with the following assumptions and weighted average fair values:

Year EndedDecember 31, 2023
Valuation assumptions:
Grant price$2.44 – $3.78
Exercise price$2.44 – $3.78
Expected dividend yield0%
Expected volatility73.77% – 86.24%
Expected life (in years)2.50 – 3.75
Risk-free interest rate4.19% – 4.65%

The fair value of the Company’s stock options granted in the year ended December 31, 2019, that are being classified as liability awards were marked-to-market using the Black-Scholes option pricing model with the following assumptions and weighted average fair values:

Year EndedDecember 31, 2023
Valuation assumptions:
Exercise price$2.68
Expected dividend yield0%
Expected volatility range for grants after mark-to-market adjustment79.88% - 82.02%
Expected life (in years) for grants after mark-to-market adjustment0.08 – 0.54
Risk-free interest rate range for grants after mark-to-market adjustment4.80% - 5.59%

Stock option activity during the periods indicated below was as follows:

Number ofSharesSubject toIssuanceWeighted- average Exercise PriceWeighted- average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at December 31, 2021496,424$6.133.03 years$528
Granted732,2282.14
Forfeited(108,408)4.53
Outstanding at December 31, 20221,120,244$3.683.50 years$84
Granted627,5072.91
Forfeited(595,037)4.05
Exercised——
Outstanding at December 31, 20231,152,714$3.073.18 years$38
Exercisable at December 31, 2023550,964$3.472.33 years$23

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on December 31, 2023. This amount changes based upon the fair market value of the Company’s stock.

The following is a summary of stock options as of December 31, 2023:

Options Outstanding · Options Exercisable
Range of Exercise PricesNumber of OptionsWeighted- average Remaining LifeWeighted-average Exercise PriceNumber of OptionsWeighted- average Exercise Price
$1.71 to $3.691,024,3983.95 years$2.47484,081$2.35
$3.78 to $11.50128,3162.85 years$8.0066,883$11.50
1,152,7143.18 years$3.07550,964$3.47

The weighted-average fair value of the options granted during the year ended December 31, 2023 is $2.91. All stock options have been issued with an exercise price that is equal or above the fair market value of the Company’s Common Stock on the date of grant.

Restricted Stock Units

The Company periodically issues Restricted Stock Units (“RSUs”) which are equity-based instruments that may be settled in shares of common stock of the Company. The Company issues RSUs to certain directors as compensation which vest with the passage of time. The vesting of all RSUs is contingent on continued board and employment services.

The compensation expense incurred by the Company for RSUs is based on the closing market price of the Company’s common stock on the date of grant, is amortized on a straight-line basis over the requisite service period and charged to operating expenses with a corresponding increase to additional paid-in capital, reduced by forfeitures when they occur.

Restricted stock unit activity during the periods indicated below is as follows:

Number of SharesWeightedAverage Grant DateFair Value
Outstanding at December 31, 2021408,376$10.43
Granted139,9582.23
Forfeited(36,445)10.35
Vested and Settled in shares(296,997)8.03
Outstanding at December 31, 2022214,892$8.43
Granted249,4122.34
Forfeited(70,959)10.04
Vested and Settled in shares(332,845)4.29
Outstanding December 31, 202360,500$4.23

Performance Stock Units

On August 7, 2020, the Company issued 265,942 Performance Stock Units (PSUs) to its officers and certain employees as compensation (“PSU Plan”).50% of the PSUs were to vest based on the Company’s market price and 50% were to vest based on the Company’s Adjusted EBITDA. Both the conditions were to occur over a specified time and were contingent on continued employment services.

On November 4, 2021, the Company amended its PSU Plan so that 100% of the PSUs will vest based on the Company’s market price as the sole vesting criteria. As a result of this amendment, the Adjusted EBITDA performance metric is no longer a vesting criterion.

The fair value of these awards with a market condition was estimated, at the date of grant, using the Monte Carlo Simulation model with compensation expense being determined on the closing market price of the Company’s common stock on the date of grant and is amortized ratably on a straight-line basis over the requisite service period. Following the amendment mentioned above which provided that the Company's market price is the sole vesting criteria for these awards, compensation expense is charged to operating expenses with a corresponding increase to additional paid-in capital and is not reversed if the vesting criteria is not met. All outstanding PSUs vested during the year ended December 31, 2023 and as of December 31, 2023 there wereno outstanding PSUs.

Number of SharesWeightedAverage Grant DateFair Value
Outstanding at December 31, 2021228,498$7.91
Forfeited(50,810)7.91
Outstanding at December 31, 2022177,688$7.91
Forfeited(88,844)7.91
Vested and settled in shares(88,844)7.91
Outstanding at December 31, 2023—$—

As of December 31, 2023, there was $822 of total unrecognized compensation costs, related to all unvested stock options, and RSUs. These costs are expected to be recognized as compensation expense over a weighted average period of approximately 1.96 years.

Stock-based compensation expense for the years ended December 31, 2023 and 2022 is as follows:

Years Ended December 31,
20232022
Stock options$666$382
Restricted stock units9301,342
Performance stock units—731
$1,596$2,455

Stock-based compensation is included in operating expenses as follows:

Years Ended December 31,
20232022
Selling, general and administrative$1,358$1,789
Research and development238666
$1,596$2,455

As of December 31, 2023, the Company had 1,138,925 shares available for future grants under the Company’s equity compensation plans.

Warrants

All previously granted warrants were issued with an exercise price that was equal to or above the fair market value of the Company’s common stock on the date of grant. As of December 31, 2023, the Company hadno remaining warrants outstanding and all the warrants expired unexercised.

  1. COMMITMENTS AND CONTINGENCIES

Leases

The Company leases an office in Melville, New York. Rent expense, which includes utilities, was $68 and $78 for the years ended December 31, 2023 and 2022 and is included in Selling, general and administrative expenses on the Statement of Operations.

The Company determines if an arrangement is a lease at lease inception. The arrangement is a lease if it conveys the right to the Company to control the use of identified property, plant, or equipment for a period of time in exchange for consideration. The Company didnot have an Operating Lease ROU or Operating Lease Liability as of December 31, 2023, as its office lease is on a month-to-month term and allows for either party to terminate the lease without a significant penalty.

Legal Proceedings

The Company is not aware of any infringement by our products or technology on the proprietary rights of others.

From time to time, the Company may be involved in lawsuits, claims, investigations and proceedings, consisting of intellectual property, commercial, employment and other matters, which arise in the ordinary course of business. In accordance with GAAP, the Company records a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, ruling, advice of legal counsel and other information and events pertaining to a particular case. Litigation is inherently unpredictable. If any unfavorable ruling was to occur in any specific period or if a loss becomes probable and estimable, there exists the possibility of a material adverse impact on the Company’s results of operations, financial position or cash flows. As of December 31, 2023, no material amounts are recorded related to legal proceedings on the balance sheets. The Company recently received a class action complaint in March 2024, and while we are unable to fully assess the probability and outcome of the matter due to recency of the filing, the Company does not currently believe that a material loss is probable. As such, the Company has not recognized a liability and intends to fully defend the matter.

Cash Incentive Plans

In May 2020, the Board implemented a 2020 separate executive incentive bonus plan (“the 2020 Bonus Plan”) with the Company’s executive management team. Each agreement, under the 2020 Bonus Plan, is based on certain goals achieved by the Company plus individual achievements by each executive.

In June 2020, the Company’s executive management team created a 2020 Employee Incentive Plan for all the Company’s non-executives and non-sales personnel. The incentive payment is based on the Company attaining certain revenue goals for the calendar year 2023 and is based as a percentage of the employee’s salary.

At December 31, 2023 and 2022, this bonus liability for the executive and employee bonus plans amounted to $824 and $846 and is included in the Accrued Expenses on the Balance Sheets as well as the Accrued Expenses table in Note 7.

  1. RETIREMENT PLAN

The Company has a retirement savings 401(k) plan. The plan permits eligible employees to make voluntary contributions to a trust, up to a maximum of 35% of compensation, subject to certain limitations. The Company has elected to contribute a matching contribution equal to 50% of the first 6% of an eligible employee’s deferral election. The Company may also make discretionary contributions, subject to certain conditions, as defined in the plan. The Company’s matching contributions were $108 and $118 for 2023 and 2022, respectively.

  1. REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS

In connection with the preparation of its financial statements for the year ended December 31, 2023, the Company determined that it had a historical state sales and use tax liability related to prior periods. The Company is required and subject to collect and remit sales and use taxes in state and local jurisdictions where it has economic nexus. During the year ended December 31, 2023, the Company determined that a sales tax liability related to the periods of 2019 through 2023 was probable and determined an estimated liability for sales transactions processed in jurisdictions where it had not previously reported. The Company determined that its previously issued financial statements for the period ended December 31, 2022 did not reflect the liability that was estimated to exist for that period. The correction of these errors had no effect on the total cash flows from operations, investing, or financing of the Company.

In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (“SAB 99”) and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” (“SAB 108”), the Company evaluated the additional liability and has determined that the related impact was immaterial to the previously issued financial statements; however, correcting the liability in the current period would have a material impact on the current financial statements. Therefore, the Company, in consultation with the Audit Committee of the Company’s Board of Directors, concluded that the affected periods should be revised to present the identified adjustments. The Company has not filed, and does not intend to file, an amendment to the previously filed Annual Report on Form 10-K for the period ended December 31, 2022, but instead is revising its previously reported financial statements in this Annual Report on Form 10-K.

All financial statements and footnotes presented herein have been adjusted to reflect the revisions below.

As of March 31, 2022
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$1,768605$2,373
Accumulated deficit$(128,365)(605)$(128,970)
Total stockholders’ equity$18,938(605)$18,333
As of June 30, 2022
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$2,321677$2,998
Accumulated deficit$(129,463)(677)$(130,140)
Total stockholders’ equity$18,360(677)$17,683
As of September 30, 2022
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$2,036751$2,787
Accumulated deficit$(130,187)(751)$(130,938)
Total stockholders’ equity$18,332(751)$17,581
As of December 31, 2022
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$2,319837$3,156
Accumulated deficit$(130,748)(837)$(131,585)
Total stockholders’ equity$18,504(837)$17,667
As of March 31, 2023
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$2,475908$3,383
Accumulated deficit$(132,064)(908)$(132,972)
Total stockholders’ equity$17,830(908)$16,922
As of June 30, 2023
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$1,980984$2,964
Accumulated deficit$(132,841)(984)$(133,825)
Total stockholders’ equity$17,337(984)$16,353
As of September 30, 2023
As Previously ReportedAdjustmentAs adjusted
BALANCE SHEET
Accrued expenses$2,3501,064$3,414
Accumulated deficit$(133,485)(1,064)$(134,549)
Total stockholders’ equity$17,071(1,064)$16,007
For the Three Months Ended March 31, 2022
As Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$2,94376$3,019
Total operating expenses$4,54776$4,623
Loss from operations$(1,468)(76)$(1,544)
Net loss$(1,468)(76)$(1,544)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.08)$—$(0.08)
For the Three Months Ended June 30, 2022For the Six Months Ended June 30, 2022
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$3,12472$3,196$6,068148$6,216
Total operating expenses$4,74272$4,814$9,289148$9,437
Loss from operations$(1,098)(72)$(1,170)$(2,566)(148)$(2,714)
Net loss$(1,098)(72)$(1,170)$(2,566)(148)$(2,714)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.06)$—$(0.06)$(0.14)$—$(0.14)
For the Three Months Ended September 30, 2022For the Nine Months Ended September 30, 2022
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$2,91774$2,991$8,985222$9,207
Total operating expenses$4,37874$4,452$13,667222$13,889
Loss from operations$(724)(74)$(798)$(3,290)(222)$(3,512)
Net loss$(724)(74)$(798)$(3,290)(222)$(3,512)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.04)$—$(0.04)$(0.17)$(0.02)$(0.19)
For the Year Ended December 31, 2022
As Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$12,399308$12,707
Total operating expenses$18,413308$18,721
Loss from operations$(3,722)(308)$(4,030)
Net loss$(3,851)(308)$(4,159)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.20)$(0.02)$(0.22)
For the Three Months Ended March 31, 2023
As Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$3,92471$3,995
Total operating expenses$5,23271$5,303
Loss from operations$(1,310)(71)$(1,381)
Net loss$(1,316)(71)$(1,387)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.07)$—$(0.07)
For the Three Months Ended June 30, 2023For the Six Months Ended June 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$3,86176$3,937$7,784147$7,931
Total operating expenses$5,13776$5,213$10,368147$10,515
Loss from operations$(773)(76)$(849)$(2,082)(147)$(2,229)
Net loss$(777)(76)$(853)$(2,093)(147)$(2,240)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.04)$—$(0.04)$(0.11)$(0.01)$(0.12)
For the Three Months Ended September 30, 2023For the Nine Months Ended September 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF OPERATIONS
Selling, general and administrative expenses$3,59780$3,677$11,382227$11,609
Total operating expenses$5,14780$5,227$15,516227$15,743
Loss from operations$(815)(80)$(895)$(2,898)(227)$(3,125)
Net loss$(644)(80)$(724)$(2,737)(227)$(2,964)
PER SHARE INFORMATION
Loss per common share
Basic and Diluted$(0.03)$(0.01)$(0.04)$(0.14)$(0.01)$(0.15)
As Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(7,478)(529)$(8,007)
Accumulated deficit$(126,897)(529)$(127,426)
Total Stockholders’ Equity$19,577(529)$19,048
For the Three Months Ended March 31, 2022For the Three Months Ended March 31, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(1,468)(76)$(1,544)$(1,316)(71)$(1,387)
Accumulated deficit$(128,365)(605)$(128,970)$(132,064)(908)$(132,972)
Total Stockholders’ Equity$18,938(605)$18,333$17,830(908)$16,922
For the Three Months Ended June 30, 2022For the Three Months Ended June 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(1,098)(72)$(1,170)$(777)(76)$(853)
Accumulated deficit$(129,463)(677)$(130,140)$(132,841)(984)$(133,825)
Total Stockholders’ Equity$18,360(677)$17,683$17,337(984)$16,353
For the Three Months Ended September 30, 2022For the Three Months Ended September 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(724)(74)$(798)$(644)(80)$(724)
Accumulated deficit$(130,187)(751)$(130,938)$(133,485)(1,064)$(134,549)
Total Stockholders’ Equity$18,332(751)$17,581$17,071(1,064)$16,007
For the Six Months Ended June 30, 2022For the Six Months Ended June 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(2,566)(148)$(2,714)$(2,093)(147)$(2,240)
Accumulated deficit$(129,463)(677)$(130,140)$(132,841)(984)$(133,825)
Total Stockholders’ Equity$18,360(677)$17,683$17,337(984)$16,353
For the Nine Months Ended September 30, 2022For the Nine Months Ended September 30, 2023
As Previously ReportedAdjustmentAs adjustedAs Previously ReportedAdjustmentAs adjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(3,290)(222)$(3,512)$(2,737)(227)$(2,964)
Accumulated deficit$(130,187)(751)$(130,938)$(133,485)(1,064)$(134,549)
Total Stockholders’ Equity$18,332(751)$17,581$17,071(1,064)$16,007
As Previously Reported · Adjustment · Asadjusted
STATEMENT OF STOCKHOLDERS’ EQUITY
Net loss$(3,851)(308)$(4,159)
Accumulated deficit$(130,748)(837)$(131,585)
Total Stockholders’ Equity$18,504(837)$17,667
For the Three Months Ended March 31, 2022
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(1,468)(76)$(1,544)
Increase (decrease) in accounts payable and accrued expenses$(1,149)76$(1,073)
For the Six Months Ended June 30, 2022
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(2,566)(148)$(2,714)
Increase (decrease) in accounts payable and accrued expenses$(497)148$(349)
For the Nine Months Ended September 30, 2022
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(3,290)(222)$(3,512)
Increase (decrease) in accounts payable and accrued expenses$(588)222$(366)
For the year ended December 31, 2022
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(3,851)(308)$(4,159)
Increase (decrease) in accounts payable and accrued expenses$(568)308$(260)
For the Three Months Ended March 31, 2023
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(1,316)(71)$(1,387)
Increase (decrease) in accounts payable and accrued expenses$71271$783
For the Six Months Ended June 30, 2023
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(2,093)(147)$(2,240)
Increase (decrease) in accounts payable and accrued expenses$(22)147$125
For the Nine Months Ended September 30, 2023
As Previously ReportedAdjustmentAs Adjusted
STATEMENT OF CASH FLOWS
Net loss$(2,737)(227)$(2,964)
Increase (decrease) in accounts payable and accrued expenses$204227$431
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.